Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.

DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML.

Blood. 2002 May 15;99(10):3780-5.

2.

Production of secretory IgA antibodies in plants.

Larrick JW, Yu L, Naftzger C, Jaiswal S, Wycoff K.

Biomol Eng. 2001 Oct 15;18(3):87-94. Review.

PMID:
11566600
3.

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.

Naftzger C, Takechi Y, Kohda H, Hara I, Vijayasaradhi S, Houghton AN.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14809-14.

4.

A melanosomal membrane protein is a cell surface target for melanoma therapy.

Takechi Y, Hara I, Naftzger C, Xu Y, Houghton AN.

Clin Cancer Res. 1996 Nov;2(11):1837-42.

5.

HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family.

Nossner E, Goldberg JE, Naftzger C, Lyu SC, Clayberger C, Krensky AM.

J Exp Med. 1996 Feb 1;183(2):339-48.

6.

Recognition of autoantigens by patients with melanoma.

Houghton AN, Vijayasaradhi S, Bouchard B, Naftzger C, Hara I, Chapman PB.

Ann N Y Acad Sci. 1993 Aug 12;690:59-68. Review. No abstract available.

PMID:
8368771
7.

Tumor immunology.

Naftzger C, Houghton AN.

Curr Opin Oncol. 1991 Feb;3(1):93-9. Review.

PMID:
2043699

Supplemental Content

Loading ...
Support Center